维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="AWH CC"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Sustained benefits from ranibizumab for macular edema following central retinal vein Occlusion:twelve-month outcomes of a phase Ⅲ study显示文摘	Campochiaro PA Brown DM Awh CC		0，，：	1
2	HORIZON: an open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration 显示文摘	Singer MA Awh CC Sadda S	2012	Ophthalmology2012，119，6：	1
3	HORIZON: an openlabel extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular degeneration 显示文摘	Singer MA Awh CC Sadda S	2012	Ophthalmology2012，119，6：	1
4	Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration 显示文摘	Boyer DS Antoszyk AN Awh CC	2007	Ophthalmology2007，114，2：	1
5	HORIZON: An open-label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macu- lar dengeration 显示文摘	Singer MA Awh CC Sadda S Freeman WR Antoszyk AN Wong P	2012	Ophthalmology2012，119，6：	1
6	Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study显示文摘	Campochiaro PA Brown DM Awh CC	2011	Ophthalmology2011，118，10：	1
7	Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study 显示文摘	Campochiaro PA Brown DM Awh CC	2011	Ophthalmology2011，118，：	1
8	Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase II study显示文摘	Campochiaro PA Brown DM Awh CC	2011	Ophthalmology2011，118，10：	1
9	HORIZON: An open- label extension trial of ranibizumab for choroidal neovascularization secondary to age-related macular dengeration显示文摘	Singer MA Awh CC Sadda S	2012	Ophthalmology2012，119，6：	1
10	Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration 显示文摘	Boyer DS Antoszyk AN Awh CC Bhisitkul RB Shapiro H Acharya NR	2007	Ophthalmology2007，114，2：	1
11	Subgroup a- nalysis of the MARINA study of ranibizumab in neovascular age-related mactflar degeneration显示文摘	BOYER DS ANTOSZYK AN AWH CC BHISrrKUL RB SHA- PIRO H ACHARYA NRMARINA Study Group	2007	Ophthalmology2007，114，2：	1
12	Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration显示文摘	Boyer DS Antoszyk AN Awh CC	2007	Ophthalmology2007，114，：	1
13	HORIZON: an Open-Label extension trial of ranibizumab for choroidal neovascu- larization secondary to Age-Related macular degeneration 显示文摘	Singer MA Awh CC Sadda SV	2012	Ophthalmology2012，119，6：	1
14	Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degeneration显示文摘	Boyer DS Antoszyk AN Awh CC	2007	Ophthalmology2007，114，2：	1
15	Sustained benefits from ranibizumab for macular edema following central retinal vein oc- clusion : twelve month outcomes of a phase III study显示文摘	Campochiaro PA Brown DM Awh CC	2011	Ophthalmol- ogy2011，118，10：	1
16	Novel mercury vapor illuminator combined with a 27/29-gauge chldelier light fiber for vitreous surgery 显示文摘	Oshima Y Chow DR Awh CC	2008	Retina2008，28，：	1
17	Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion:twelve-month outcomes of a phase III study显示文摘	Campochiaro PA Brown DM Awh CC	2011	Ophthalmology2011，118，10：	1
18	Subgroup anslyisis of The MARINA stu- dy of rainbizumab in ncovascular age-re- lated macular degeneration显示文摘	Boyer DS Antoszyk AN Awh CC	2007	Ophthlmolgy2007，11，4：	1
19	Self-retaining 27-gauge transconjunctival chandelier endoillumination for panoramic viewing during vitreous surgery显示文摘	Oshima Y Awh CC Tano Y		0，，：	1
20	Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion:twelve month outcomes of a phase Ⅲ study显示文摘	Campochiaro PA Brown DM Awh CC Lee SY Gray S Saroj N		0，，10：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示